$29.64
+0.10 (+0.34%)
Open$29.71
Previous Close$29.54
Day High$30.39
Day Low$29.01
52W High$35.86
52W Low$11.39
Volume—
Avg Volume1.29M
Market Cap189.94M
P/E Ratio—
EPS$-35.79
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
-73.2% upside
Current
$29.64
$29.64
Target
$7.94
$7.94
$5.53
$7.94 avg
$9.87
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.47M | 8.37M | 49.01M |
| Net Income | -380,405,045 | -524,455,484 | -2,802,997 |
| Profit Margin | -6,960.8% | -6,612.7% | -5.7% |
| EBITDA | -65,314,515 | -95,050,228 | -4,562,575 |
| Free Cash Flow | — | — | -4,055,082 |
| Rev Growth | -34.7% | -34.7% | +7.4% |
| Debt/Equity | — | — | 0.82 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |